These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 21093488

  • 1. Viral entry inhibitors block dengue antibody-dependent enhancement in vitro.
    Nicholson CO, Costin JM, Rowe DK, Lin L, Jenwitheesuk E, Samudrala R, Isern S, Michael SF.
    Antiviral Res; 2011 Jan; 89(1):71-4. PubMed ID: 21093488
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Antibody-independent and dependent infection of human myeloid cells with dengue virus is inhibited by carrageenan.
    Piccini LE, Carro AC, Quintana VM, Damonte EB.
    Virus Res; 2020 Dec; 290():198150. PubMed ID: 32866533
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Dengue virus neutralization and antibody-dependent enhancement activities of human monoclonal antibodies derived from dengue patients at acute phase of secondary infection.
    Sasaki T, Setthapramote C, Kurosu T, Nishimura M, Asai A, Omokoko MD, Pipattanaboon C, Pitaksajjakul P, Limkittikul K, Subchareon A, Chaichana P, Okabayashi T, Hirai I, Leaungwutiwong P, Misaki R, Fujiyama K, Ono K, Okuno Y, Ramasoota P, Ikuta K.
    Antiviral Res; 2013 Jun; 98(3):423-31. PubMed ID: 23545366
    [Abstract] [Full Text] [Related]

  • 7. Molecular determinants of dengue virus 2 envelope protein important for virus entry in FcγRIIA-mediated antibody-dependent enhancement of infection.
    Chotiwan N, Roehrig JT, Schlesinger JJ, Blair CD, Huang CY.
    Virology; 2014 May; 456-457():238-46. PubMed ID: 24889243
    [Abstract] [Full Text] [Related]

  • 8. Dengue virus (DENV) antibody-dependent enhancement of infection upregulates the production of anti-inflammatory cytokines, but suppresses anti-DENV free radical and pro-inflammatory cytokine production, in THP-1 cells.
    Chareonsirisuthigul T, Kalayanarooj S, Ubol S.
    J Gen Virol; 2007 Feb; 88(Pt 2):365-375. PubMed ID: 17251552
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A prospective nested case-control study of Dengue in infants: rethinking and refining the antibody-dependent enhancement dengue hemorrhagic fever model.
    Libraty DH, Acosta LP, Tallo V, Segubre-Mercado E, Bautista A, Potts JA, Jarman RG, Yoon IK, Gibbons RV, Brion JD, Capeding RZ.
    PLoS Med; 2009 Oct; 6(10):e1000171. PubMed ID: 19859541
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Antibody-dependent enhancement of dengue virus infection in U937 cells requires cholesterol-rich membrane microdomains.
    Puerta-Guardo H, Mosso C, Medina F, Liprandi F, Ludert JE, del Angel RM.
    J Gen Virol; 2010 Feb; 91(Pt 2):394-403. PubMed ID: 19828759
    [Abstract] [Full Text] [Related]

  • 19. Blockade of dengue virus entry into myeloid cells by endocytic inhibitors in the presence or absence of antibodies.
    Carro AC, Piccini LE, Damonte EB.
    PLoS Negl Trop Dis; 2018 Aug; 12(8):e0006685. PubMed ID: 30092029
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.